Streetbeat News

Equity Actions

HEPA

Hepion Pharmaceuticals has exercised a Series B common stock purchase warrant for 980,393 shares, resulting in gross proceeds of approximately $2M. This move indicates a potential boost in the company's financial position and could reflect positively on its stock performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 1:10 pm

GLOB

Globant (NYSE:GLOB) received mixed analyst ratings with an updated average 12-month price target of $268.88, marking a 17.78% increase from the previous target. The company shows strong financial health with notable revenue growth and profitability, despite a below-average market capitalization and ROE. Analysts from firms like Piper Sandler and JP Morgan have raised their price targets, reflecting optimism about Globant's future performance.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 1:00 pm

AMX

America Movil (NYSE:AMX) received mixed analyst ratings over the past three months, with an average 12-month price target of $21.13, reflecting a 6.77% increase from the previous target. The company, a leading telecom carrier in Latin America, faces challenges in revenue growth and return on equity, despite its strong market position and cost management.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 1:00 pm

PVH

PVH Corp (NYSE:PVH) has been analyzed by 14 analysts, showing a mix of bullish to indifferent sentiments. Recent updates include raised price targets and ratings, reflecting a positive outlook on the company's performance. The average 12-month price target is now $116.86, up 17.8% from $99.20, indicating analysts' increased confidence in PVH's market standing. Financial indicators such as market capitalization, revenue growth, net margin, and ROE are strong, though ROA and debt management present areas for improvement.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 1:00 pm

DTM

DT Midstream has updated its financial outlook, increasing its 2024 Adjusted EBITDA guidance to $930M-$980M and providing an early outlook for 2025 with an Adjusted EBITDA range of $980M-$1.04B, indicating a 6% annual growth from 2024. The company also forecasts 2024 Adjusted EPS to be between $3.43 and $3.83, compared to the estimated $3.85.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 12:15 pm

QDEL

QuidelOrtho has revised its 2024 financial guidance, widening the range for adjusted EPS to $1.88-$3.60 from the previously announced $2.40-$3.07. This adjustment is made to align with the adjusted EBITDA guidance, while the midpoint of the adjusted EPS range remains unchanged.

Portfolio Pulse from Benzinga Newsdesk

February 16, 2024 | 12:09 pm

GKOS

Analyst ratings for Glaukos (NYSE:GKOS) have shown a mix of perspectives, with recent updates indicating a generally positive outlook. The average 12-month price target for GKOS has been raised to $93.43, up 8.64% from the previous $86.00. Analysts from firms like Needham, Truist Securities, Piper Sandler, JP Morgan, and Morgan Stanley have maintained or raised their ratings and price targets, reflecting optimism about the company's future performance. Glaukos, an ophthalmic medical technology company, has shown a revenue growth rate of 9.51% as of September 30, 2023, but struggles with profitability and financial efficiency, as indicated by its below-industry-average net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 12:01 pm

FND

Floor & Decor Holdings (NYSE:FND) received mixed ratings from 7 analysts, with an average 12-month price target of $100.71, indicating a 20.37% increase from the previous target. The company shows strong revenue growth and net margin but lags in ROE. Its debt management and ROA are above industry averages.

Portfolio Pulse from Benzinga Insights

February 16, 2024 | 12:00 pm

FBK

KRNY

PLCE

TCBI

Insiders have recently made notable purchases in shares of Texas Capital Bancshares, Kearny Financial, FB Financial, and Children's Place, indicating their confidence in these companies. These transactions suggest potential growth or undervaluation of these stocks. Kearny Financial revised its Q2 fiscal 2024 results, Texas Capital Bancshares reported downbeat quarterly earnings, FB Financial increased its quarterly dividend, and Children's Place received a notification of significant ownership by Mithaq Capital.

Portfolio Pulse from Avi Kapoor

February 16, 2024 | 11:51 am

BGNE

PRDSY

XPEV

The Hang Seng Index is set to expand by potentially including Prada (OTC:PRDSY), XPeng (NYSE:XPEV), and BeiGene (NASDAQ:BGNE) in its upcoming quarterly review. This move aims to boost the global market presence and appeal of Hong Kong's stock market, which has faced challenges including a more than 6% drop this year. The inclusion of foreign and electric vehicle companies could enhance the market's diversity and attractiveness to global companies.

Portfolio Pulse from Benzinga Neuro

February 16, 2024 | 11:19 am